Also known as
Other names:
- PL14736, PL-10
Brand names:
- Bepecin
- Pentadecapeptide
Therapeutic Goods Administration (TGA) approval
BPC-157 is not approved by the TGA.
World Anti-Doping Code Prohibited List 2024
S0- Non-approved Substances (prohibited at all times).
|
Check medications, find batch-tested supplements and more:
Download the Sport Integrity App
|
The Prohibited List is updated yearly after consultation with scientific, medical, and anti-doping experts to ensure that it aligns with the latest medical and scientific evidence and doping trends.
What is it?
BPC-157 is a synthetically produced peptide. It is an experimental drug which is not approved by TGA or any global regulatory authority for human use. Its use may lead to serious negative health effects.
Uses
BPC-157 is not approved for therapeutic use. It is an experimental compound that has been initially investigated for inflammatory bowel disease and soft tissue, but its benefits have not been substantiated.
Adverse health effects and risk
The toxicity profile of BPC-157 including the short-term and long-term safety of its intake is unknown. Its use may lead to serious health effects.